J. Brechot (Paris, France), R. M. Huber (Munich, Germany)
Surgery in the treatment of lung cancer during the last three decades
M. Marel, Z. Skacel, I. Spasova, B. Stastny, L. Melinova (Prague, Czech Republic)
|  |
Quality of life in patients with non-small cell lung cencer treated by radioterapy
M. Rancic, D. J. Zivkovic, S. Rancic, M. Cekic, T. Pejcic, L. Ristic, D. Djordjevic, I. Stankovic (Nis, Yugoslavia)
| |
Quality of life in patients with non-small cell lung cancer treated by chemotherapy
M. Rancic, D. J. Zivkovic, S. Rancic, M. Cekic, L. Ristic, T. Pejcic, I. Stankovic, D. Djordjevic (Nis, Yugoslavia)
| |
Pulmonary toxicity during chemotherapy with etopiside and carboplatin
M. Mincarini, O. Andreani, E. Cerri (Genoa, Italy)
| |
Use of adjuvants to chemotherapy in stage IV nonsmall cell lung carcinoma (NSCLC)
J. M. Bréchot, N. Roche, F. Vlastos, P. J. Souquet, G. Darneau, D. Debieuvre, L. Falchero, C. Marichy, M. Grivaux, E. Coste, B. Lebeau (Paris, France)
| |
Gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer
I. Spasova, E. Illichova, V. Bartos, M. Marel (Prague, Hradec Kralove, Czech Republic)
| |
Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)?
D. Antoniou, I. Karidis, G. Pavlakou, P. Mihalopoulou, D. Haimala, A. Tsimogiani, K. Papasarantopoulou (Athens, Greece)
| |
Use of 2nd-line polychemotherapy in advanced nonsmall cell lung cancer – a reasonable approach
N. J. Dickgreber, D. Lindemann, T. Klante, H. C. Buschmann, T. Welte (Magdeburg, Germany)
| |
Second line chemotherapy with cisplatin (C) plus paclitaxel (P) for chemo refractory and resistant SCLC patients (pts). Did it change the overall disease’s prognosis?
P. Barradas, A. Lopes, A. Costa, M. Cristovao, A. Alves, M. J. Melo (Lisboa, Portugal)
| |
A comparison between the toxic side effects of adriamycin, cyclophosphamide, and etoposide (ACE) and carboplatin with etoposide (CbE) in the treatment of small cell lung cancer (SCLC)
N. Diar-Bakerly, N. P. Keaney, I. K. Taylor, K. Sridharan, H. W. Clague (Sunderland, United Kingdom)
| |
Management of small cell lung cancer in Norway
H. Rostad, A. Naalsund, R. Jacobsen, T. E. Strand, J. Norstein (Oslo, Norway)
| |
Temozolomide in the treatment of brain metastases in lung cancer patients
E. J. Mylonaki, N. T. Samaras, P. H. Kakavelas, P. K. Stiropoulos, P. G. Christaki (Exochi, Greece)
| |
Pulmonary cancer with cerebral metastases: algorithm of the treatment
F. M. Gramada, D. Gramada, N. Ianovici, A. Esanu, I. Poeata (Iasi, Romania)
| |
Palliation of bone metastases-related pain in lung carcinoma
G. D. Radosavljevic-Asic, D. Subotic, D. Jovanovic, L. Nagorni, T. Adzic (Belgrade, Yugoslavia)
| |
Treatment of a carcinoid tumor with somatostatin analogue
M. Hubner, A. Odelga, B. Plakolm, F. Kummer (Wien, Austria)
| |